Top Markets
Coin of the day
AIM ImmunoTech Inc. AIM ImmunoTech Inc.

AIM ImmunoTech Inc.

AIM
Rang in aandelen #38739
AIM ImmunoTech Inc., an immuno-pharmaceutical company based in Ocala, Florida,... AIM ImmunoTech Inc., an immuno-pharmaceutical company based in Ocala, Florida, focuses on discovering and advancing treatments for a diverse array of cancers, viral infections, and immune system disorders across the United States. Its primary drug offerings include Ampligen (rintatolimod), a large macromolecular double-stranded ribonucleic acid compound developed for chronic fatigue syndrome, and Alferon N Injection (Interferon alfa), a purified, naturally derived, multi-species alpha interferon prescribed for genital warts. Furthermore, Ampligen is currently undergoing investigation for its potential application in treating pancreatic, renal cell, malignant melanoma, non-small cell lung, ovarian, breast, colorectal, and prostate cancers, as well as myalgic encephalomyelitis, Hepatitis B, HIV, COVID-19, and post-COVID conditions. The company, originally incorporated in 1966, was formerly known as Hemispherx Biopharma, Inc. until its name change in August 2019.
Aandeelprijs
$0.2443
Marktkapitalisatie
$831.49K
Verandering (1 dag)
-5.42%
Verandering (1 jaar)
-89.90%
Land
US
Handel AIM ImmunoTech Inc. (AIM)

Categorie

Prijs AIM met de marktkapitalisatie van B
AIM ImmunoTech Inc. AIM ImmunoTech Inc.
AIM
$0.2443
Marktkapitalisatie van AIM ImmunoTech Inc.(AIM)
Marktkapitalisatie: $831.49K
Vanaf August 2026 heeft AIM ImmunoTech Inc. een marktkapitalisatie van $831.49K. Dit maakt AIM ImmunoTech Inc. volgens onze gegevens het 38739th meest waardevolle bedrijf ter wereld op basis van marktkapitalisatie. De marktkapitalisatie is de totale marktwaarde van alle uitstaande aandelen van een beursgenoteerd bedrijf en wordt vaak gebruikt om de waarde van een bedrijf te meten.
Marktkapitalisatiegeschiedenis van AIM ImmunoTech Inc. van 1996 tot 2026
AIM vergeleken met de top 5 populairste stocks
Prijs voor AIM Aandeel B Marktkapitalisatie van B uitslagen
AIM ImmunoTech Inc. AIM ImmunoTech Inc.
$1,602,232 $831.49K
$5.453T +655,846,058.79%
AIM ImmunoTech Inc. AIM ImmunoTech Inc.
$1,318,718 $831.49K
$4.488T +539,794,367.38%
AIM ImmunoTech Inc. AIM ImmunoTech Inc.
$1,222,597 $831.49K
$4.161T +500,448,998.04%
AIM ImmunoTech Inc. AIM ImmunoTech Inc.
$1,086,592 $831.49K
$3.698T +444,777,489.63%
AIM ImmunoTech Inc. AIM ImmunoTech Inc.
$833,093 $831.49K
$2.835T +341,012,011.66%